A new mesalazine foam enema (Claversal Foam) compared with a standard liquid enema in patients with active distal ulcerative colitis. [electronic resource]
- Alimentary pharmacology & therapeutics Mar 2002
- 415-23 p. digital
Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S.
0269-2813
10.1046/j.1365-2036.2002.01199.x doi
Adolescent Adult Aged Anti-Inflammatory Agents, Non-Steroidal--administration & dosage Colitis, Ulcerative--drug therapy Dosage Forms Endoscopy, Gastrointestinal Enema--adverse effects Female Humans Male Mesalamine--administration & dosage Middle Aged Patient Compliance Patient Satisfaction Quality of Life Remission Induction Treatment Outcome